Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort

D A Lomas, E K Silverman, Lisa D Edwards, B E Miller, H O Coxson, R Tal-Singer, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators, Bill Macnee

Research output: Contribution to journalArticlepeer-review

Abstract

Circulating levels of Clara cell secretory protein-16 (CC-16) have been linked to Clara cell toxicity. It has therefore been suggested that this protein may be a useful marker of chronic obstructive pulmonary disease (COPD).
Original languageEnglish
Pages (from-to)1058-63
Number of pages6
JournalThorax
Volume63
Issue number12
DOIs
Publication statusPublished - 2008

Fingerprint Dive into the research topics of 'Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort'. Together they form a unique fingerprint.

Cite this